Gara Jalqabaatti › HIV › California › San Francisco
Qorannoo klinikaalii HIV San Francisco, CA keessatti
Qorannoo 15 HIV f San Francisco fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Bridge HIV CRS, San Francisco
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Namoota walitti qabaa jiraQorannoo ilaalaa
- San Francisco General Hospital, San Francisco
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Namoota walitti qabaa jiraSadarkaa 3
- Optimus Medical Group, San Francisco
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Namoota walitti qabaa jiraSadarkaa 2
- University of California, San Francisco, San Francisco
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Namoota walitti qabaa jira
- University of California, San Francisco, San Francisco
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Francisco, San Francisco
Menopausal HT for Women Living With HIV (HoT)
Namoota walitti qabaa jiraSadarkaa 4
- 801 University of California, San Francisco HIV/AIDS CRS, San Francisco
CAR-T Cells for HIV Infection
Namoota walitti qabaa jiraSadarkaa 1/2
- Zuckerberg San Francisco General, San Francisco
SCOPE Analytic Treatment Interruption Protocol
Namoota walitti qabaa jira
- University of California San Francisco, San Francisco
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Namoota walitti qabaa jiraSadarkaa 2
- San Francisco General Hospital, San Francisco
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Bridge HIV, San Francisco Department of Public Health, San Francisco
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Francisco, San Francisco
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Namoota walitti qabaa jira
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California San Francisco, San Francisco
Imaging Immune Activation in HIV by PET-MR
Namoota walitti qabaa jiraSadarkaa 2
- University of California, San Francisco, San Francisco
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- San Francisco AIDS Foundation, San Francisco
Qorannoo HIV magaalota biroo keessatti
- Washington, DCQorannoo 22
- New York City, NYQorannoo 19
- Houston, TXQorannoo 17
- Miami, FLQorannoo 17
- Baltimore, MDQorannoo 16
- Chicago, ILQorannoo 14
- Atlanta, GAQorannoo 14
- Philadelphia, PAQorannoo 11
- Boston, MAQorannoo 11
- San Diego, CAQorannoo 10
- Los Angeles, CAQorannoo 9
- Seattle, WAQorannoo 8
Qorannoo biroo San Francisco keessatti
- Kansarii ProstateQorannoo 45
- Saree OljooQorannoo 43
- Kansara Qara'a Non-Small CellQorannoo 36
- Saree (Gosoota Hunda)Qorannoo 35
- Cufama OnneeQorannoo 29
- Kansara MetastatikiiQorannoo 28
- Dhibee QaraQorannoo 22
- MelanomaQorannoo 22
- Kansarii PancreasQorannoo 20
- Kansarii OvariiQorannoo 19
- Kansarii ColorectalQorannoo 18
- Dhibee Onneessaa fi DhiigaQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.